Ondine Non Currrent Assets Other vs Total Assets Analysis

OBI Stock   12.00  0.25  2.04%   
Ondine Biomedical financial indicator trend analysis is much more than just breaking down Ondine Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ondine Biomedical is a good investment. Please check the relationship between Ondine Biomedical Non Currrent Assets Other and its Total Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Non Currrent Assets Other vs Total Assets

Non Currrent Assets Other vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ondine Biomedical Non Currrent Assets Other account and Total Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Ondine Biomedical's Non Currrent Assets Other and Total Assets is -0.21. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Total Assets in the same time period over historical financial statements of Ondine Biomedical, assuming nothing else is changed. The correlation between historical values of Ondine Biomedical's Non Currrent Assets Other and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Ondine Biomedical are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Currrent Assets Other i.e., Ondine Biomedical's Non Currrent Assets Other and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.21
Relationship DirectionNegative 
Relationship StrengthInsignificant

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Total Assets

Total assets refers to the total amount of Ondine Biomedical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ondine Biomedical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Ondine Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ondine Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
As of February 16, 2025, Selling General Administrative is expected to decline to about 7.8 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 4.2 M
 2022 2023 2024 2025 (projected)
Interest Expense30K38K34.2K32.5K
Depreciation And Amortization493K587K528.3K517.3K

Ondine Biomedical fundamental ratios Correlations

-0.380.780.28-0.8-0.490.411.0-0.43-0.211.00.23-0.27-0.080.39-0.361.0-0.430.320.89-0.430.58-0.31-0.20.170.52
-0.38-0.87-0.170.850.1-0.5-0.360.15-0.31-0.370.240.310.29-0.041.0-0.380.990.29-0.240.99-0.450.21-0.340.34-0.44
0.78-0.870.24-0.99-0.310.550.77-0.310.10.78-0.07-0.37-0.230.2-0.860.78-0.89-0.040.62-0.890.61-0.290.12-0.120.54
0.28-0.170.24-0.33-0.710.320.32-0.76-0.070.330.470.11-0.140.82-0.140.35-0.240.630.32-0.250.63-0.81-0.10.110.69
-0.80.85-0.99-0.330.37-0.57-0.790.41-0.1-0.8-0.040.360.24-0.30.84-0.80.88-0.06-0.670.88-0.640.38-0.110.12-0.6
-0.490.1-0.31-0.710.37-0.68-0.470.540.66-0.48-0.56-0.520.03-0.890.09-0.520.2-0.64-0.640.21-0.830.450.64-0.59-0.89
0.41-0.50.550.32-0.57-0.680.38-0.37-0.380.390.280.26-0.130.56-0.50.43-0.560.160.56-0.570.73-0.26-0.40.40.79
1.0-0.360.770.32-0.79-0.470.38-0.49-0.151.00.26-0.33-0.070.41-0.341.0-0.410.350.89-0.420.56-0.38-0.140.130.5
-0.430.15-0.31-0.760.410.54-0.37-0.49-0.18-0.5-0.730.270.04-0.80.13-0.510.23-0.61-0.60.24-0.340.97-0.180.18-0.6
-0.21-0.310.1-0.07-0.10.66-0.38-0.15-0.18-0.15-0.21-0.83-0.06-0.37-0.32-0.18-0.26-0.35-0.33-0.25-0.51-0.320.98-0.91-0.41
1.0-0.370.780.33-0.8-0.480.391.0-0.5-0.150.27-0.32-0.080.42-0.351.0-0.420.350.9-0.420.56-0.39-0.140.120.52
0.230.24-0.070.47-0.04-0.560.280.26-0.73-0.210.270.14-0.120.760.260.30.130.830.560.130.2-0.63-0.180.140.47
-0.270.31-0.370.110.36-0.520.26-0.330.27-0.83-0.320.140.060.330.3-0.280.260.22-0.090.260.320.3-0.780.710.36
-0.080.29-0.23-0.140.240.03-0.13-0.070.04-0.06-0.08-0.120.06-0.040.29-0.080.3-0.01-0.080.3-0.120.09-0.080.08-0.12
0.39-0.040.20.82-0.3-0.890.560.41-0.8-0.370.420.760.33-0.04-0.010.46-0.140.720.63-0.150.62-0.75-0.350.290.87
-0.361.0-0.86-0.140.840.09-0.5-0.340.13-0.32-0.350.260.30.29-0.01-0.360.990.31-0.230.99-0.440.19-0.340.34-0.42
1.0-0.380.780.35-0.8-0.520.431.0-0.51-0.181.00.3-0.28-0.080.46-0.36-0.430.370.91-0.430.59-0.4-0.170.150.56
-0.430.99-0.89-0.240.880.2-0.56-0.410.23-0.26-0.420.130.260.3-0.140.99-0.430.18-0.321.0-0.520.28-0.280.29-0.53
0.320.29-0.040.63-0.06-0.640.160.35-0.61-0.350.350.830.22-0.010.720.310.370.180.460.170.46-0.53-0.390.390.43
0.89-0.240.620.32-0.67-0.640.560.89-0.6-0.330.90.56-0.09-0.080.63-0.230.91-0.320.46-0.330.53-0.45-0.280.210.67
-0.430.99-0.89-0.250.880.21-0.57-0.420.24-0.25-0.420.130.260.3-0.150.99-0.431.00.17-0.33-0.530.29-0.280.28-0.54
0.58-0.450.610.63-0.64-0.830.730.56-0.34-0.510.560.20.32-0.120.62-0.440.59-0.520.460.53-0.53-0.28-0.550.570.8
-0.310.21-0.29-0.810.380.45-0.26-0.380.97-0.32-0.39-0.630.30.09-0.750.19-0.40.28-0.53-0.450.29-0.28-0.320.32-0.56
-0.2-0.340.12-0.1-0.110.64-0.4-0.14-0.180.98-0.14-0.18-0.78-0.08-0.35-0.34-0.17-0.28-0.39-0.28-0.28-0.55-0.32-0.98-0.36
0.170.34-0.120.110.12-0.590.40.130.18-0.910.120.140.710.080.290.340.150.290.390.210.280.570.32-0.980.29
0.52-0.440.540.69-0.6-0.890.790.5-0.6-0.410.520.470.36-0.120.87-0.420.56-0.530.430.67-0.540.8-0.56-0.360.29
Click cells to compare fundamentals

Ondine Biomedical Account Relationship Matchups

Ondine Biomedical fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets2.6M34.1M16.6M5.7M6.6M9.0M
Total Current Liabilities35.8M3.9M3.9M3.5M4.0M3.8M
Total Stockholder Equity(33.8M)29.7M11.6M2.1M1.9M2.0M
Property Plant And Equipment Net671K601K1.4M949K1.1M663.6K
Net Debt30.8M(29.6M)(12.2M)(2.4M)(2.8M)(2.7M)
Retained Earnings(182.1M)(232.5M)(251.9M)(266.3M)(239.7M)(227.7M)
Accounts Payable237K1.2M388K1.4M1.6M923.0K
Cash626K30.4M13.1M3.0M3.4M4.5M
Non Current Assets Total888K636K1.4M984K1.1M1.3M
Non Currrent Assets Other40K46K35K36K31.5K29.9K
Cash And Short Term Investments626K30.4M13.1M3.0M3.4M5.6M
Net Receivables543K248K133K220K198K269.6K
Liabilities And Stockholders Equity2.6M34.1M16.6M5.7M6.6M9.0M
Non Current Liabilities Total678K561K1.0M159K182.9K173.7K
Other Stockholder Equity28.8M27.2M28.5M28.8M33.1M33.0M
Total Liab36.5M4.5M4.9M3.6M4.2M4.0M
Total Current Assets1.7M33.5M15.1M4.8M5.5M7.7M
Short Long Term Debt Total31.5M739K896K541K622.2K591.0K
Other Current Liab4.2M2.1M3.2M1.7M2.0M1.0M
Other Current Assets717K2.1M710K703K632.7K1.1M
Short Term Debt31.4M645K359K382K439.3K417.3K
Inventory404K1.1M1.3M1.1M1.2M646.2K
Capital Lease Obligations310K242K896K541K622.2K469.7K
Net Invested Capital334K30.2M11.6M2.1M2.4M2.3M
Net Working Capital(34.0M)29.6M11.2M1.3M1.4M1.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ondine Stock

Balance Sheet is a snapshot of the financial position of Ondine Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Ondine Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ondine Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ondine currently owns. An asset can also be divided into two categories, current and non-current.